Literature DB >> 28003097

Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.

Sachin H Patel1, Fernando D Camargo2, Dean Yimlamai3.   

Abstract

The Hippo signaling pathway, also known as the Salvador-Warts-Hippo pathway, is a regulator of organ size. The pathway takes its name from the Drosophila protein kinase, Hippo (STK4/MST1 and STK3/MST2 in mammals), which, when inactivated, leads to considerable tissue overgrowth. In mammals, MST1 and MST2 negatively regulate the transcriptional co-activators yes-associated protein 1 and WW domain containing transcription regulator 1 (WWTR1/TAZ), which together regulate expression of genes that control proliferation, survival, and differentiation. Yes-associated protein 1 and TAZ activation have been associated with liver development, regeneration, and tumorigenesis. How their activity is dynamically regulated in these contexts is just beginning to be elucidated. We review the mechanisms of Hippo signaling in the liver and explore outstanding questions for future research.
Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  TAZ; WWTR1; YAP1; YES-Associated Protein

Mesh:

Substances:

Year:  2016        PMID: 28003097      PMCID: PMC5285449          DOI: 10.1053/j.gastro.2016.10.047

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  125 in total

1.  IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism.

Authors:  Daisaku Yamada; Sumera Rizvi; Nataliya Razumilava; Steven F Bronk; Jaime I Davila; Mia D Champion; Mitesh J Borad; Jorge A Bezerra; Xin Chen; Gregory J Gores
Journal:  Hepatology       Date:  2015-03-20       Impact factor: 17.425

2.  YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers.

Authors:  Giorgio G Galli; Matteo Carrara; Wei-Chien Yuan; Christian Valdes-Quezada; Basanta Gurung; Brian Pepe-Mooney; Tinghu Zhang; Geert Geeven; Nathanael S Gray; Wouter de Laat; Raffaele A Calogero; Fernando D Camargo
Journal:  Mol Cell       Date:  2015-10-01       Impact factor: 17.970

3.  A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.

Authors:  J A Trofatter; M M MacCollin; J L Rutter; J R Murrell; M P Duyao; D M Parry; R Eldridge; N Kley; A G Menon; K Pulaski
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

4.  Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.

Authors:  Daniela Sia; Yujin Hoshida; Augusto Villanueva; Sasan Roayaie; Joana Ferrer; Barbara Tabak; Judit Peix; Manel Sole; Victoria Tovar; Clara Alsinet; Helena Cornella; Brandy Klotzle; Jian-Bing Fan; Christian Cotsoglou; Swan N Thung; Josep Fuster; Samuel Waxman; Juan Carlos Garcia-Valdecasas; Jordi Bruix; Myron E Schwartz; Rameen Beroukhim; Vincenzo Mazzaferro; Josep M Llovet
Journal:  Gastroenterology       Date:  2013-01-04       Impact factor: 22.682

5.  Hippo pathway activity influences liver cell fate.

Authors:  Dean Yimlamai; Constantina Christodoulou; Giorgio G Galli; Kilangsungla Yanger; Brian Pepe-Mooney; Basanta Gurung; Kriti Shrestha; Patrick Cahan; Ben Z Stanger; Fernando D Camargo
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

6.  Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.

Authors:  Yun-Yong Park; Bo Hwa Sohn; Randy L Johnson; Myoung-Hee Kang; Sang Bae Kim; Jae-Jun Shim; Lingegowda S Mangala; Ji Hoon Kim; Jeong Eun Yoo; Cristian Rodriguez-Aguayo; Sunila Pradeep; Jun Eul Hwang; Hee-Jin Jang; Hyun-Sung Lee; Rajesha Rupaimoole; Gabriel Lopez-Berestein; Woojin Jeong; Inn Sun Park; Young Nyun Park; Anil K Sood; Gordon B Mills; Ju-Seog Lee
Journal:  Hepatology       Date:  2015-11-26       Impact factor: 17.425

7.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.

Authors:  Dawang Zhou; Claudius Conrad; Fan Xia; Ji-Sun Park; Bernhard Payer; Yi Yin; Gregory Y Lauwers; Wolfgang Thasler; Jeannie T Lee; Joseph Avruch; Nabeel Bardeesy
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

8.  Yes-associated protein impacts adherens junction assembly through regulating actin cytoskeleton organization.

Authors:  Haibo Bai; Qingfeng Zhu; Alexandra Surcel; Tianzhi Luo; Yixin Ren; Bin Guan; Ying Liu; Nan Wu; Nora Eve Joseph; Tian-Li Wang; Nailing Zhang; Duojia Pan; Gianfranco Alpini; Douglas N Robinson; Robert A Anders
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-05-26       Impact factor: 4.052

9.  The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.

Authors:  Nailing Zhang; Haibo Bai; Karen K David; Jixin Dong; Yonggang Zheng; Jing Cai; Marco Giovannini; Pentao Liu; Robert A Anders; Duojia Pan
Journal:  Dev Cell       Date:  2010-07-20       Impact factor: 12.270

10.  A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.

Authors:  Toshiro Moroishi; Hyun Woo Park; Baodong Qin; Qian Chen; Zhipeng Meng; Steven W Plouffe; Koji Taniguchi; Fa-Xing Yu; Michael Karin; Duojia Pan; Kun-Liang Guan
Journal:  Genes Dev       Date:  2015-06-15       Impact factor: 11.361

View more
  97 in total

1.  MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes.

Authors:  Yong He; Seonghwan Hwang; Yan Cai; Seung-Jin Kim; Mingjiang Xu; Dingcheng Yang; Adrien Guillot; Dechun Feng; Wonhyo Seo; Xin Hou; Bin Gao
Journal:  Hepatology       Date:  2019-06-05       Impact factor: 17.425

Review 2.  Human-relevant preclinical in vitro models for studying hepatobiliary development and liver diseases using induced pluripotent stem cells.

Authors:  Pooja Chaudhari; Lipeng Tian; Zhaohui Ye; Yoon-Young Jang
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-26

Review 3.  Cellular and molecular basis of liver regeneration.

Authors:  Sushant Bangru; Auinash Kalsotra
Journal:  Semin Cell Dev Biol       Date:  2020-01-22       Impact factor: 7.727

Review 4.  Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.

Authors:  Luca Fabris; Romina Fiorotto; Carlo Spirli; Massimiliano Cadamuro; Valeria Mariotti; Maria J Perugorria; Jesus M Banales; Mario Strazzabosco
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08       Impact factor: 46.802

5.  Not the comfy chair! Cancer drugs that act against multiple active sites.

Authors:  Laurence Booth; Andrew Poklepovic; Paul Dent
Journal:  Expert Opin Ther Targets       Date:  2019-11-14       Impact factor: 6.902

6.  YAP-TEAD signaling promotes basal cell carcinoma development via a c-JUN/AP1 axis.

Authors:  Dejan Maglic; Karin Schlegelmilch; Antonella Fm Dost; Riccardo Panero; Michael T Dill; Raffaele A Calogero; Fernando D Camargo
Journal:  EMBO J       Date:  2018-07-23       Impact factor: 11.598

Review 7.  On the Molecular Mechanisms Regulating Animal Cell Size Homeostasis.

Authors:  Evgeny Zatulovskiy; Jan M Skotheim
Journal:  Trends Genet       Date:  2020-02-20       Impact factor: 11.639

8.  The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans.

Authors:  Shu Zhang; Jie Zhang; Katja Evert; Xiaolei Li; Pin Liu; Andras Kiss; Zsuzsa Schaff; Cindy Ament; Yi Zhang; Monica Serra; Matthias Evert; Nianyong Chen; Feng Xu; Xin Chen; Junyan Tao; Diego F Calvisi; Antonio Cigliano
Journal:  Am J Pathol       Date:  2020-04-10       Impact factor: 4.307

9.  Low-density lipoprotein receptor-related protein-1 dysfunction synergizes with dietary cholesterol to accelerate steatohepatitis progression.

Authors:  Allyson N Hamlin; Sivaprakasam Chinnarasu; Yinyuan Ding; Xunde Xian; Joachim Herz; Anja Jaeschke; David Y Hui
Journal:  J Biol Chem       Date:  2018-05-11       Impact factor: 5.157

10.  Liver regeneration requires Yap1-TGFβ-dependent epithelial-mesenchymal transition in hepatocytes.

Authors:  Seh-Hoon Oh; Marzena Swiderska-Syn; Mark L Jewell; Richard T Premont; Anna Mae Diehl
Journal:  J Hepatol       Date:  2018-05-23       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.